LINDSEY GASKINS: Open Payments
NPI 1740995059 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 44 payments from 12 companies in 2025. Trend: 2023 $153 · 2024 $116 · 2025 $1,388
Food & beverage: $1,212Education: $176
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $474 |
| ABBVIE INC. | 16 | $233 |
| Phathom Pharmaceuticals, Inc. | 5 | $222 |
| Madrigal Pharmaceuticals | 1 | $150 |
| Stryker Corporation | 2 | $79 |
| GENZYME CORPORATION | 2 | $52 |
| QOL Medical, LLC | 2 | $46 |
| EVOKE PHARMA, INC. | 2 | $32 |
| Novo Nordisk Inc | 1 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
Products named: TREMFYA, VOQUEZNA, REZDIFFRA, SKYRIZI, RINVOQ, LINZESS, MAKO, DUPIXENT.
Industry payments across LA — which companies pay providers there.
